Brieyanna C. McWilliams

Brieyanna C. McWilliams

Auto-generated profile, based on publicly available information

Brieyanna C. McWilliams

Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 June 2026 in Science Translational Medicine
Verified
Journal Article
Closed access
AÖArya B. Ökten
Arya B. Ökten
RFRenata B. Filler
Renata B. Filler
JKJustin L. Kung
Justin L. Kung
ZFZhenhao Fang
Zhenhao Fang
BMBrieyanna C. McWilliams
Brieyanna C. McWilliams
CWCraig Wilen
Craig Wilen
Human norovirus is the leading cause of viral gastroenteritis, yet effective vaccines and therapeutics remain elusive. Using murine norovirus as a model, we found that mucosal immunoglobulin A (IgA) is both necessary and sufficient for protection against infection, whereas CD8 + T cells are dispensable. Robust intestinal IgA production requires at least 4 weeks of enteric infection, consistent with kinetics of human norovirus RNA clearance. Systemic vaccination elicits high titers of neutralizing serum IgG but fails to prevent enteric norovirus infection, phenocopying a recent human norovirus vaccine failure. In contrast, prophylactic delivery of dimeric anti-norovirus IgA via mRNA lipid nanoparticles confers sterilizing immunity. Together, these findings define a critical role for mucosal IgA in norovirus protection and identify IgA-based treatments as a therapeutic approach for human norovirus.